IDEXX Laboratories Inc. (IDXX): Price and Financial Metrics

IDEXX Laboratories Inc. (IDXX): $529.81

0.04 (+0.01%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

A

IDXX Price/Volume Stats

Current price $529.81 52-week high $583.39
Prev. close $529.77 52-week low $372.50
Day low $529.00 Volume 379,500
Day high $535.69 Avg. volume 440,155
50-day MA $548.96 Dividend yield N/A
200-day MA $500.22 Market Cap 44.02B

IDXX Stock Price Chart Interactive Chart >

IDXX POWR Grades

  • Quality is the dimension where IDXX ranks best; there it ranks ahead of 93.96% of US stocks.
  • IDXX's strongest trending metric is Growth; it's been moving down over the last 26 weeks.
  • IDXX ranks lowest in Momentum; there it ranks in the 27th percentile.

IDXX Stock Summary

  • IDEXX LABORATORIES INC's market capitalization of $44,437,643,672 is ahead of 94.27% of US-listed equities.
  • The price/operating cash flow metric for IDEXX LABORATORIES INC is higher than 93.8% of stocks in our set with a positive cash flow.
  • IDXX's price/sales ratio is 12.39; that's higher than the P/S ratio of 91.13% of US stocks.
  • If you're looking for stocks that are quantitatively similar to IDEXX LABORATORIES INC, a group of peers worth examining would be CARR, FTV, CSGP, XYL, and ALGN.
  • IDXX's SEC filings can be seen here. And to visit IDEXX LABORATORIES INC's official web site, go to www.idexx.com.

IDXX Valuation Summary

  • In comparison to the median Healthcare stock, IDXX's price/earnings ratio is 92.11% higher, now standing at 56.
  • IDXX's EV/EBIT ratio has moved up 26.6 over the prior 243 months.

Below are key valuation metrics over time for IDXX.

Stock Date P/S P/B P/E EV/EBIT
IDXX 2023-12-29 12.8 35.5 56.0 43.4
IDXX 2023-12-28 12.9 35.7 56.2 43.5
IDXX 2023-12-27 12.9 35.7 56.2 43.5
IDXX 2023-12-26 12.9 35.6 56.1 43.5
IDXX 2023-12-22 12.8 35.5 55.9 43.3
IDXX 2023-12-21 12.8 35.4 55.8 43.2

IDXX Growth Metrics

    Its 5 year price growth rate is now at 65.5%.
  • Its 2 year net cashflow from operations growth rate is now at 64.77%.
  • Its year over year revenue growth rate is now at 14.56%.
IDXX's revenue has moved up $1,197,347,000 over the prior 52 months.

The table below shows IDXX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 3,367.324 542.984 679.089
2022-09-30 3,339.846 579.52 669.653
2022-06-30 3,308.606 577.725 663.95
2022-03-31 3,274.202 745.83 734.553
2021-12-31 3,215.36 755.546 744.845
2021-09-30 3,135.208 764.516 756.864

IDXX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IDXX has a Quality Grade of A, ranking ahead of 96.19% of graded US stocks.
  • IDXX's asset turnover comes in at 1.342 -- ranking 14th of 680 Pharmaceutical Products stocks.
  • IMGN, RMTI, and MTEX are the stocks whose asset turnover ratios are most correlated with IDXX.

The table below shows IDXX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.342 0.588 0.424
2021-03-31 1.325 0.589 0.389
2020-12-31 1.322 0.580 0.344
2020-09-30 1.341 0.576 0.319
2020-06-30 1.332 0.572 0.314
2020-03-31 1.366 0.567 0.313

IDXX Price Target

For more insight on analysts targets of IDXX, see our IDXX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $717.50 Average Broker Recommendation 1.56 (Moderate Buy)

IDEXX Laboratories Inc. (IDXX) Company Bio


IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 and headquartered in Westbrook, Maine, and EMEA in Hoofddorp, Netherlands, IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions (as of 7 February 2020). There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy (LPD). In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. (Source:Wikipedia)


IDXX Latest News Stream


Event/Time News Detail
Loading, please wait...

IDXX Latest Social Stream


Loading social stream, please wait...

View Full IDXX Social Stream

Latest IDXX News From Around the Web

Below are the latest news stories about IDEXX LABORATORIES INC that investors may wish to consider to help them evaluate IDXX as an investment opportunity.

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.

Yahoo | December 18, 2023

Should You Add IDEXX Laboratories (IDXX) to Your Portfolio?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy outperformed the Russell Midcap Growth Index and returned -4.11% (net) while the index return was -5.22%. The third quarter saw a decline in […]

Yahoo | December 18, 2023

Insider Sell: Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc

In a notable insider transaction, Executive Vice President James Polewaczyk has parted with 11,636 shares of IDEXX Laboratories Inc (NASDAQ:IDXX), a leader in veterinary diagnostics, software, and water microbiology testing.

Yahoo | December 9, 2023

Insider Sell: President and CEO Jonathan Mazelsky Sells Shares of IDEXX Laboratories Inc (IDXX)

In a notable insider transaction, President and CEO Jonathan Mazelsky has parted with 7,128 shares of IDEXX Laboratories Inc (NASDAQ:IDXX), a leader in veterinary diagnostics, veterinary practice software, and water microbiology testing.

Yahoo | December 8, 2023

IDEXX Laboratories Schedules Two Institutional Investor Events

WESTBROOK, Maine, December 07, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events:

Yahoo | December 7, 2023

Read More 'IDXX' Stories Here

IDXX Price Returns

1-mo -4.63%
3-mo -2.91%
6-mo 16.35%
1-year 12.40%
3-year 9.27%
5-year 141.62%
YTD -4.55%
2023 36.06%
2022 -38.04%
2021 31.73%
2020 91.43%
2019 40.38%

Continue Researching IDXX

Here are a few links from around the web to help you further your research on Idexx Laboratories Inc's stock as an investment opportunity:

Idexx Laboratories Inc (IDXX) Stock Price | Nasdaq
Idexx Laboratories Inc (IDXX) Stock Quote, History and News - Yahoo Finance
Idexx Laboratories Inc (IDXX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!